Oncology
The sponsor is deeply engaged in the field of oncology, with a particular focus on Hodgkin lymphoma. Their research efforts are directed towards improving treatment outcomes for patients with early-stage disease through innovative trial designs.
- Hodgkin Lymphoma
- Progression Free Survival
- PET-response Adapted Design
By exploring new therapeutic combinations and response-adapted strategies, the sponsor aims to enhance the efficacy of existing treatments and contribute to the advancement of personalized cancer therapy.
Endocrinology
In the realm of endocrinology, the sponsor is committed to addressing Growth Hormone Deficiency (GHD). Their research is focused on understanding the impact of growth hormone therapy on final height outcomes in affected individuals.
- Growth Hormone Deficiency
- Final Height Standard Deviation Score
- Mid-parental Target Height
Through their studies, the sponsor seeks to refine treatment protocols and improve quality of life for patients with hormonal deficiencies, thereby contributing to the broader field of pediatric endocrinology.
